LUCY WON: Open Payments
NPI 1497172613 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,436 in 95 payments from 11 companies in 2025. Trend: 2023 $388 · 2024 $2,017 · 2025 $2,436
Food & beverage: $2,436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $380 |
| Alkermes, Inc. | 12 | $348 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $302 |
| Lundbeck LLC | 9 | $267 |
| Janssen Pharmaceuticals, Inc | 6 | $241 |
| Otsuka America Pharmaceutical, Inc. | 9 | $237 |
| E.R. Squibb & Sons, L.L.C. | 9 | $229 |
| Almatica Pharma LLC | 9 | $205 |
| Axsome Therapeutics, Inc. | 6 | $160 |
| Corium, LLC | 2 | $50 |
Products named: REXULTI, VRAYLAR, ARISTADA, CAPLYTA, SPRAVATO, COBENFY, LOREEV XR, Auvelity.
Industry payments across CA — which companies pay providers there.
